---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-017571"
form_type: "8-K"
ticker: "LFMD"
cik: "0000948320"
company_name: "LifeMD, Inc."
filed_at: "2024-05-02T23:59:59+00:00"
generated_at: "2026-06-03T01:41:48.661014+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# LifeMD appoints Dr. Calum MacRae, Harvard cardiologist, to board

## Summary
- Dr. MacRae appointed as independent director effective April 26, 2024.
- He is Vice Chair for Scientific Innovation, Brigham and Women's Hospital, and Harvard professor.
- Compensation: 50,000 restricted shares vesting in three annual tranches through 2027.
- MacRae's expertise includes cardiology, virtual care, and chronic disease management.
- Press release issued April 29, 2024; no other material changes reported.

## SEC filing metadata
- accession: 0001493152-24-017571
- form_type: 8-K
- ticker: LFMD
- cik: 0000948320
- company_name: LifeMD, Inc.
- filed_at: 2024-05-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/948320/000149315224017571/0001493152-24-017571-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/948320/000149315224017571/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-017571
- JSON: https://secwatch.observer/filing/0001493152-24-017571.json
- Plain text: https://secwatch.observer/filing/0001493152-24-017571.txt

## Key facts
- Executive change
  Calum MacRae was appointed as Member of the Board of Directors at LifeMD, Inc..
  - Action: appointed
  - Role: Member of the Board of Directors
  source text: On April 26, 2024, Calum MacRae was appointed to the Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/948320/000149315224017571/0001493152-24-017571-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.